gh Increased Use Of Generics

A groundbreaking study released Jan. 31 predicts a Medicare prescription drug benefit beginning 2005 could cost $50 to $100 billion less if private sector generic drug incentives are broadly applied. Executive Summary Pre-Publication Draft




The Bush administration will issue a proposed rulemaking soon that will expand SCHIP coverage to pregnant women for their children who are not yet born.







Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.